Day: July 28, 2025

BURNABY, British Columbia, July 28, 2025 (GLOBE NEWSWIRE) — INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) announced today that it recently closed an early renewal and extension of its revolving credit facility with its syndicate of major Canadian and U.S. banks. The commitment amount under the facility was renewed at approximately C$560 million, and the maturity of the facility has been extended from December 2026 to July 2029. The renewal includes several improved provisions that will enhance the Company’s financial flexibility, including a higher threshold as to when a minimum EBITDA interest coverage ratio covenant may apply. In addition, Interfor also renewed its private shelf note purchase agreement with PGIM Inc., the principal asset management business of Prudential Financial. The shelf note purchase agreement...

MONTREAL, July 28, 2025 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland” or the “Corporation”) (TSX-V: MD) is pleased to announce the closing of a previously announced private placement (see press release dated July 22, 2025), for gross proceeds of $5,058,750 from the sale of 10,650,000 shares of the Corporation (each a “FT Share”) at a price of $0.475 per FT Share. Each FT Share will qualify as a “flow-through share” within the meaning of subsection 66(15) of the Income Tax Act (Canada) (“Tax Act”). As part of the private placement, Midland is pleased to welcome Centerra Gold Inc. (“Centerra”) (TSX: CG) (NYSE: CGAU) as a new strategic investor. Centerra now holds approximately 9.9% of the Corporation’s issued and outstanding common shares. Midland is also pleased to announce the closing of a concurrent non-brokered private...

– ATH434 Demonstrated Clinical Benefit on the Unified MSA Rating Scale and Global Measures of Neurological Symptoms – – Neuroimaging Biomarkers Showed Target Engagement and Slowed Brain Atrophy – – ATH434 was Well-Tolerated with Favorable Safety Profile – – Data are Consistent with Phase 2 Double-Blind Trial and Support Advancement of ATH434 in MSA – MELBOURNE, Australia and SAN FRANCISCO, July 28, 2025 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced positive topline data from the ATH434-202 open-label Phase 2 clinical trial in individuals with multiple system atrophy (MSA). The ATH434-202 trial evaluated a patient population with more advanced disease than...

OMAHA, Neb., July 28, 2025 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (NYSE American: EXOD) (“Exodus”), a leading self-custodial cryptocurrency platform, today announced that it will provide a business update and release its second quarter financial results on Monday, August 11, 2025, after market close. An earnings conference webcast will be held at 4:30 PM ET on the same day. To access the webcast, please use this link. It will also be available on the Company’s website www.exodus.com. Supplementary materials will also be made available prior to the webcast on the “Investor Relations” portion of the Company website. About Exodus Exodus is a financial technology leader empowering individuals and businesses with secure, user-friendly crypto software solutions. Since 2015, Exodus has made digital assets accessible to everyone...

CEDAR PARK, Texas, July 28, 2025 (GLOBE NEWSWIRE) — Firefly Aerospace, a market leading space and defense technology company, today announced that it has launched the roadshow for its proposed initial public offering of 16,200,000 shares of its common stock. In addition, Firefly intends to grant the underwriters a 30-day option to purchase an additional 2,430,000 shares of its common stock at the initial public offering price, less underwriting discounts and commissions. The initial public offering price is expected to be between $35.00 and $39.00 per share. Firefly intends to use its net proceeds from this offering to repay outstanding borrowings under its credit agreement, pay any accrued and unpaid dividends on certain series of its preferred stock, and for general corporate purposes. Firefly has applied to list its common...

Earnings Release: Thursday, July 31, 2025, Before Market OpensConference Call and Webcast: Thursday, July 31, 2025, at 8:30 a.m. ET MONACO, July 28, 2025 (GLOBE NEWSWIRE) — Costamare Inc. (NYSE:CMRE) (the “Company”), announced today that it will release its results for the second quarter ended June 30, 2025 before the market opens in New York on July 31, 2025. Conference Call Details: On Thursday, July 31, 2025 at 8:30 a.m. ET, Costamare’s management team will hold a conference call to discuss the financial results. Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 1-844-887-9405 (from the US), 0808-238-9064 (from the UK) or +1-412-317-9258 (from outside the US). Please quote “Costamare”. A replay of the conference call will be available until August 7, 2025. The...

ANN ARBOR, Mich., July 28, 2025 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), a world leader in spider silk technology*, today announced the formal signing of a multi-year agreement with a government agency in Southeast Asia to support the scale-up of its recombinant spider silk production. This agreement is the result of many years of groundwork by Kraig Labs and marks a significant step in the Company’s ongoing efforts to commercialize next-generation biomaterials. Under the terms of the agreement, Kraig Labs will gain access to government-supported rearing facilities, technical personnel, and infrastructure critical to accelerating production and expanding operational capacity. “This milestone reflects many years of work by our senior management...

Infortar will organize a webinar for investors on 4 August 2025 at 12:00 (EET) in Estonian and at 14:00 (EET) in English to introduce the second quarter 2025 results. The webinar will be attended by the Chairman of the Board of Infortar Ain Hanschmidt, the Managing Director Martti Talgre and Investor Relations Manager Kadri Laanvee. The webinar will be hosted on the Microsoft Teams platform. Please note that to participate, no prior registration is required, and no reminder of the webinar will be sent. You can either participate by joining from your web browser or via Microsoft Teams application. When using a smart device to join the webinar, you first need to download the Microsoft Teams application from either Play Store or App Store. Please join the webinar via the following links: 4 August 2025 at 12:00 (EET) Estonian webinar 4 August...